APO Research
Talk to an analyst

APO RESEARCH · REPORT

Hydroxychloroquine (Plaquenil)

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global Hydroxychloroquine (Plaquenil) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025194 pages

Choose your research edition.

Industry ResearchHydroxychloroquine (Plaquenil) Industry Research Report 2026150 pages · $2,950 USDIndustry Growth & TrendsGlobal Hydroxychloroquine (Plaquenil) Industry Growth and Trends Forecast to 2032120 pages · $3,450 USDMarket StructureGlobal Hydroxychloroquine (Plaquenil) Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032194 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Hydroxychloroquine (Plaquenil) Market Outlook and Growth Opportunities 2026216 pages · $4,250 USDMarket Analysis & ForecastGlobal Hydroxychloroquine (Plaquenil) Market Analysis and Forecast 2026-2032216 pages · $4,950 USD

Market perspective

The global Hydroxychloroquine (Plaquenil) market is projected to grow from US$ million in 2026 to US$ million by 2032, implying a CAGR of % over 2026-2032.

The US & Canada market for Hydroxychloroquine (Plaquenil) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for Hydroxychloroquine (Plaquenil) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Hydroxychloroquine (Plaquenil) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for Hydroxychloroquine (Plaquenil) is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Hydroxychloroquine (Plaquenil) include Actavis (TEVA ), Advanz Pharma, Aphena Pharma, Apotex Corporation, AvKARE (Amneal Pharmaceuticals), Bristol Laboratories, Cadila Healthcare, Cardinal Health and Cinkate Corporation, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

This report provides an overview of the global Hydroxychloroquine (Plaquenil) market in terms of sales, revenue, and price, analyzing global market trends using historical revenue and sales data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of Hydroxychloroquine (Plaquenil) and sales in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents Hydroxychloroquine (Plaquenil) sales, revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering sales, revenue, and price—for 2021-2032, and evaluates and forecasts the Hydroxychloroquine (Plaquenil) market size, projected growth trends, production technologies, key applications, and end-use industries.

Hydroxychloroquine (Plaquenil) Segment by Company

Actavis (TEVA )

Advanz Pharma

Aphena Pharma

Apotex Corporation

AvKARE (Amneal Pharmaceuticals)

Bristol Laboratories

Cadila Healthcare

Cardinal Health

Cinkate Corporation

Concordia Healthcare

Covis Pharmaceutical

Hanlim Pharmaceutical

Hikma Pharmaceuticals

Ipca Laboratories

Kyung Poong

Taj Pharmaceuticals

Zydus Cadila

Mylan

Novartis

Sanofi

Shanghai Pharmaceuticals Holding

Sun Pharma

Hydroxychloroquine (Plaquenil) Segment by Type

100mg

200mg

Other

Hydroxychloroquine (Plaquenil) Segment by Application

COVID-19

Rheumatoid Arthritis

Lupus Erythematosus

Others

Hydroxychloroquine (Plaquenil) Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Hydroxychloroquine (Plaquenil) market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Hydroxychloroquine (Plaquenil) and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Hydroxychloroquine (Plaquenil).

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Provides an overview of the Hydroxychloroquine (Plaquenil) market, including product definition, global market growth prospects, market size, sales, and average price forecasts (2021-2032).

Chapter 2: Provides the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Hydroxychloroquine (Plaquenil) manufacturers competitive landscape, price, sales and revenue market share, latest development plan, merger, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Sales of Hydroxychloroquine (Plaquenil) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 7: Revenue of Hydroxychloroquine (Plaquenil) in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the market development, future development prospects, market space of each country in the world.

Chapter 8: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.

Chapter 10: Concluding Insights of the report

More report detail

Tables and figures
List of Tables Table 1. Hydroxychloroquine (Plaquenil) Industry Trends Table 2. Hydroxychloroquine (Plaquenil) Industry Drivers Table 3. Hydroxychloroquine (Plaquenil) Industry Opportunities and Challenges Table 4. Hydroxychloroquine (Plaquenil) Industry Restraints Table 5. Global Hydroxychloroquine (Plaquenil) Revenue by Manufacturers (US$ Million) & (2021-2026) Table 6. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Manufacturers (2021-2026) Table 7. Global Hydroxychloroquine (Plaquenil) Sales by Manufacturers (M Pcs) & (2021-2026) Table 8. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Manufacturers Table 9. Global Hydroxychloroquine (Plaquenil) Average Sales Price (US$/Unit) of Manufacturers (2021-2026) Table 10. Global Hydroxychloroquine (Plaquenil) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 11. Global Hydroxychloroquine (Plaquenil) Key Manufacturers Manufacturing Sites & Headquarters Table 12. Global Hydroxychloroquine (Plaquenil) Manufacturers, Product Type & Application Table 13. Global Hydroxychloroquine (Plaquenil) Manufacturers Establishment Date Table 14. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 15. Global Hydroxychloroquine (Plaquenil) by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 16. Major Manufacturers of 100mg Table 17. Major Manufacturers of 200mg Table 18. Major Manufacturers of Other Table 19. Global Hydroxychloroquine (Plaquenil) Sales by Type 2021 VS 2025 VS 2032 (M Pcs) Table 20. Global Hydroxychloroquine (Plaquenil) Sales by Type (2021-2026) & (M Pcs) Table 21. Global Hydroxychloroquine (Plaquenil) Sales by Type (2027-2032) & (M Pcs) Table 22. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Type (2021-2026) Table 23. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Type (2027-2032) Table 24. Global Hydroxychloroquine (Plaquenil) Revenue by Type 2021 VS 2025 VS 2032 (M Pcs) Table 25. Global Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2026) & (M Pcs) Table 26. Global Hydroxychloroquine (Plaquenil) Revenue by Type (2027-2032) & (M Pcs) Table 27. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Type (2021-2026) Table 28. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Type (2027-2032) Table 29. Major Manufacturers of COVID-19 Table 30. Major Manufacturers of Rheumatoid Arthritis Table 31. Major Manufacturers of Lupus Erythematosus Table 32. Major Manufacturers of Others Table 33. Global Hydroxychloroquine (Plaquenil) Sales by Application 2021 VS 2025 VS 2032 (M Pcs) Table 34. Global Hydroxychloroquine (Plaquenil) Sales by Application (2021-2026) & (M Pcs) Table 35. Global Hydroxychloroquine (Plaquenil) Sales by Application (2027-2032) & (M Pcs) Table 36. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Application (2021-2026) Table 37. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Application (2027-2032) Table 38. Global Hydroxychloroquine (Plaquenil) Revenue by Application 2021 VS 2025 VS 2032 (M Pcs) Table 39. Global Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2026) & (M Pcs) Table 40. Global Hydroxychloroquine (Plaquenil) Revenue by Application (2027-2032) & (M Pcs) Table 41. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Application (2021-2026) Table 42. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Application (2027-2032) Table 43. Global Hydroxychloroquine (Plaquenil) Sales by Region: 2021 VS 2025 VS 2032 (M Pcs) Table 44. Global Hydroxychloroquine (Plaquenil) Sales by Region (2021-2026) & (M Pcs) Table 45. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Region (2021-2026) Table 46. Global Hydroxychloroquine (Plaquenil) Sales Forecasted by Region (2027-2032) & (M Pcs) Table 47. Global Hydroxychloroquine (Plaquenil) Sales Forecasted Market Share by Region (2027-2032) Table 48. North America Hydroxychloroquine (Plaquenil) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 49. North America Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026) & (M Pcs) Table 50. North America Hydroxychloroquine (Plaquenil) Sales by Country (2027-2032) & (M Pcs) Table 51. Europe Hydroxychloroquine (Plaquenil) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 52. Europe Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026) & (M Pcs) Table 53. Europe Hydroxychloroquine (Plaquenil) Sales by Country (2027-2032) & (M Pcs) Table 54. Asia Pacific Hydroxychloroquine (Plaquenil) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 55. Asia Pacific Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026) & (M Pcs) Table 56. Asia Pacific Hydroxychloroquine (Plaquenil) Sales by Country (2027-2032) & (M Pcs) Table 57. South America, Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Growth Rate by Country: 2021 VS 2025 VS 2032 (M Pcs) Table 58. South America, Middle East and Africa Hydroxychloroquine (Plaquenil) Sales by Country (2021-2026) & (M Pcs) Table 59. South America, Middle East and Africa Hydroxychloroquine (Plaquenil) Sales by Country (2027-2032) & (M Pcs) Table 60. Global Hydroxychloroquine (Plaquenil) Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 61. Global Hydroxychloroquine (Plaquenil) Revenue by Region (2021-2026) & (US$ Million) Table 62. Global Hydroxychloroquine (Plaquenil) Revenue by Region (2027-2032) & (US$ Million) Table 63. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Region (2021-2026) Table 64. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Region (2027-2032) Table 65. Actavis (TEVA ) Company Information Table 66. Actavis (TEVA ) Business Overview Table 67. Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 68. Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Product Portfolio Table 69. Actavis (TEVA ) Recent Development Table 70. Advanz Pharma Company Information Table 71. Advanz Pharma Business Overview Table 72. Advanz Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 73. Advanz Pharma Hydroxychloroquine (Plaquenil) Product Portfolio Table 74. Advanz Pharma Recent Development Table 75. Aphena Pharma Company Information Table 76. Aphena Pharma Business Overview Table 77. Aphena Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 78. Aphena Pharma Hydroxychloroquine (Plaquenil) Product Portfolio Table 79. Aphena Pharma Recent Development Table 80. Apotex Corporation Company Information Table 81. Apotex Corporation Business Overview Table 82. Apotex Corporation Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 83. Apotex Corporation Hydroxychloroquine (Plaquenil) Product Portfolio Table 84. Apotex Corporation Recent Development Table 85. AvKARE (Amneal Pharmaceuticals) Company Information Table 86. AvKARE (Amneal Pharmaceuticals) Business Overview Table 87. AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 88. AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Product Portfolio Table 89. AvKARE (Amneal Pharmaceuticals) Recent Development Table 90. Bristol Laboratories Company Information Table 91. Bristol Laboratories Business Overview Table 92. Bristol Laboratories Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 93. Bristol Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio Table 94. Bristol Laboratories Recent Development Table 95. Cadila Healthcare Company Information Table 96. Cadila Healthcare Business Overview Table 97. Cadila Healthcare Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 98. Cadila Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio Table 99. Cadila Healthcare Recent Development Table 100. Cardinal Health Company Information Table 101. Cardinal Health Business Overview Table 102. Cardinal Health Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 103. Cardinal Health Hydroxychloroquine (Plaquenil) Product Portfolio Table 104. Cardinal Health Recent Development Table 105. Cinkate Corporation Company Information Table 106. Cinkate Corporation Business Overview Table 107. Cinkate Corporation Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 108. Cinkate Corporation Hydroxychloroquine (Plaquenil) Product Portfolio Table 109. Cinkate Corporation Recent Development Table 110. Concordia Healthcare Company Information Table 111. Concordia Healthcare Business Overview Table 112. Concordia Healthcare Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 113. Concordia Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio Table 114. Concordia Healthcare Recent Development Table 115. Covis Pharmaceutical Company Information Table 116. Covis Pharmaceutical Business Overview Table 117. Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 118. Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio Table 119. Covis Pharmaceutical Recent Development Table 120. Hanlim Pharmaceutical Company Information Table 121. Hanlim Pharmaceutical Business Overview Table 122. Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 123. Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio Table 124. Hanlim Pharmaceutical Recent Development Table 125. Hikma Pharmaceuticals Company Information Table 126. Hikma Pharmaceuticals Business Overview Table 127. Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 128. Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio Table 129. Hikma Pharmaceuticals Recent Development Table 130. Ipca Laboratories Company Information Table 131. Ipca Laboratories Business Overview Table 132. Ipca Laboratories Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 133. Ipca Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio Table 134. Ipca Laboratories Recent Development Table 135. Kyung Poong Company Information Table 136. Kyung Poong Business Overview Table 137. Kyung Poong Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 138. Kyung Poong Hydroxychloroquine (Plaquenil) Product Portfolio Table 139. Kyung Poong Recent Development Table 140. Taj Pharmaceuticals Company Information Table 141. Taj Pharmaceuticals Business Overview Table 142. Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 143. Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio Table 144. Taj Pharmaceuticals Recent Development Table 145. Zydus Cadila Company Information Table 146. Zydus Cadila Business Overview Table 147. Zydus Cadila Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 148. Zydus Cadila Hydroxychloroquine (Plaquenil) Product Portfolio Table 149. Zydus Cadila Recent Development Table 150. Mylan Company Information Table 151. Mylan Business Overview Table 152. Mylan Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 153. Mylan Hydroxychloroquine (Plaquenil) Product Portfolio Table 154. Mylan Recent Development Table 155. Novartis Company Information Table 156. Novartis Business Overview Table 157. Novartis Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 158. Novartis Hydroxychloroquine (Plaquenil) Product Portfolio Table 159. Novartis Recent Development Table 160. Sanofi Company Information Table 161. Sanofi Business Overview Table 162. Sanofi Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 163. Sanofi Hydroxychloroquine (Plaquenil) Product Portfolio Table 164. Sanofi Recent Development Table 165. Shanghai Pharmaceuticals Holding Company Information Table 166. Shanghai Pharmaceuticals Holding Business Overview Table 167. Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 168. Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Product Portfolio Table 169. Shanghai Pharmaceuticals Holding Recent Development Table 170. Sun Pharma Company Information Table 171. Sun Pharma Business Overview Table 172. Sun Pharma Hydroxychloroquine (Plaquenil) Sales (M Pcs), Price (US$/Unit), Revenue (US$ Million) and Gross Margin (2021-2026) Table 173. Sun Pharma Hydroxychloroquine (Plaquenil) Product Portfolio Table 174. Sun Pharma Recent Development Table 175. Key Raw Materials Table 176. Raw Materials Key Suppliers Table 177. Hydroxychloroquine (Plaquenil) Distributors List Table 178. Hydroxychloroquine (Plaquenil) Customers List Table 179. Research Programs/Design for This Report Table 180. Authors List of This Report Table 181. Secondary Sources Table 182. Primary Sources List of Figures Figure 1. Hydroxychloroquine (Plaquenil) Product Image Figure 2. Global Hydroxychloroquine (Plaquenil) Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Hydroxychloroquine (Plaquenil) Market Size (2021-2032) & (US$ Million) Figure 4. Global Hydroxychloroquine (Plaquenil) Sales (2021-2032) & (M Pcs) Figure 5. Global Hydroxychloroquine (Plaquenil) Average Price (US$/Unit) & (2021-2032) Figure 6. Global Top 5 and 10 Hydroxychloroquine (Plaquenil) Players Market Share by Revenue in 2025 Figure 7. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 8. 100mg Image Figure 9. 200mg Image Figure 10. Other Image Figure 11. Global Hydroxychloroquine (Plaquenil) Sales by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 12. Global Hydroxychloroquine (Plaquenil) Sales Market Share 2021 VS 2025 VS 2032 Figure 13. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Type (2021-2032) Figure 14. Global Hydroxychloroquine (Plaquenil) Revenue by Type (2021 VS 2025 VS 2032) & (M Pcs) Figure 15. Global Hydroxychloroquine (Plaquenil) Revenue Market Share 2021 VS 2025 VS 2032 Figure 16. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Type (2021-2032) Figure 17. COVID-19 Image Figure 18. Rheumatoid Arthritis Image Figure 19. Lupus Erythematosus Image Figure 20. Others Image Figure 21. Global Hydroxychloroquine (Plaquenil) Sales by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 22. Global Hydroxychloroquine (Plaquenil) Sales Market Share 2021 VS 2025 VS 2032 Figure 23. Global Hydroxychloroquine (Plaquenil) Sales Market Share by Application (2021-2032) Figure 24. Global Hydroxychloroquine (Plaquenil) Revenue by Application (2021 VS 2025 VS 2032) & (M Pcs) Figure 25. Global Hydroxychloroquine (Plaquenil) Revenue Market Share 2021 VS 2025 VS 2032 Figure 26. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Application (2021-2032) Figure 27. North America Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 28. North America Hydroxychloroquine (Plaquenil) Sales Market Share by Country (2021-2032) Figure 29. U.S. Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 30. Canada Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 31. Mexico Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 32. Europe Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 33. Europe Hydroxychloroquine (Plaquenil) Sales Market Share by Country (2021-2032) Figure 34. Germany Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 35. France Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 36. U.K. Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 37. Italy Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 38. Netherlands Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 39. Asia Pacific Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 40. Asia Pacific Hydroxychloroquine (Plaquenil) Sales Market Share by Country (2021-2032) Figure 41. China Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 42. Japan Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 43. South Korea Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 44. Southeast Asia Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 45. India Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 46. Australia Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 47. South America, Middle East and Africa Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 48. South America, Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Market Share by Country (2021-2032) Figure 49. Brazil Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 50. South Africa Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 51. Saudi Arabia Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 52. Turkey Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 53. Argentina Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 54. UAE Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 55. Egypt Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 56. Chile Hydroxychloroquine (Plaquenil) Sales and Growth Rate (2021-2032) & (M Pcs) Figure 57. Global Hydroxychloroquine (Plaquenil) Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 58. Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Region in Percentage: 2025 Versus 2032 Figure 59. North America Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Figure 60. North America Hydroxychloroquine (Plaquenil) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 61. Europe Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Figure 62. Europe Hydroxychloroquine (Plaquenil) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 63. Asia-Pacific Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Figure 64. Asia-Pacific Hydroxychloroquine (Plaquenil) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 65. South America, Middle East and Africa Hydroxychloroquine (Plaquenil) Revenue (2021-2032) & (US$ Million) Figure 66. South America, Middle East and Africa Hydroxychloroquine (Plaquenil) Revenue Share by Country: 2021 VS 2025 VS 2032 Figure 67. Hydroxychloroquine (Plaquenil) Value Chain Figure 68. Manufacturing Cost Structure Figure 69. Hydroxychloroquine (Plaquenil) Production Mode & Process Figure 70. Direct Comparison with Distribution Share Figure 71. Distributors Profiles Figure 72. Years Considered Figure 73. Research Process Figure 74. Key Executives Interviewed

Scope & coverage.

Types
  • 100mg
  • 200mg
  • Other
Applications
  • COVID-19
  • Rheumatoid Arthritis
  • Lupus Erythematosus
  • Others
Companies covered
  • Actavis (TEVA )
  • Advanz Pharma
  • Aphena Pharma
  • Apotex Corporation
  • AvKARE (Amneal Pharmaceuticals)
  • Bristol Laboratories
  • Cadila Healthcare
  • Cardinal Health
  • Cinkate Corporation
  • Concordia Healthcare
  • Covis Pharmaceutical
  • Hanlim Pharmaceutical
  • Hikma Pharmaceuticals
  • Ipca Laboratories
  • Kyung Poong
  • Taj Pharmaceuticals
  • Zydus Cadila
  • Mylan
  • Novartis
  • Sanofi
  • Shanghai Pharmaceuticals Holding
  • Sun Pharma

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Hydroxychloroquine (Plaquenil) Market Size, 2021 VS 2025 VS 2032
  3. 1.3 Global Hydroxychloroquine (Plaquenil) Market Size Estimates and Forecasts (2021-2032)
  4. 1.4 Global Hydroxychloroquine (Plaquenil) Sales Estimates and Forecasts (2021-2032)
  5. 1.5 Global Hydroxychloroquine (Plaquenil) Market Average Price (2021-2032)
  6. 1.6 Assumptions and Limitations
  7. 1.7 Study Goals and Objectives
2 Global Hydroxychloroquine (Plaquenil) Market Dynamics
  1. 2.1 Hydroxychloroquine (Plaquenil) Industry Trends
  2. 2.2 Hydroxychloroquine (Plaquenil) Industry Drivers
  3. 2.3 Hydroxychloroquine (Plaquenil) Industry Opportunities and Challenges
  4. 2.4 Hydroxychloroquine (Plaquenil) Industry Restraints
3 Hydroxychloroquine (Plaquenil) Market by Manufacturers
  1. 3.1 Global Hydroxychloroquine (Plaquenil) Revenue by Manufacturers (2021-2026)
  2. 3.2 Global Hydroxychloroquine (Plaquenil) Sales by Manufacturers (2021-2026)
  3. 3.3 Global Hydroxychloroquine (Plaquenil) Average Sales Price by Manufacturers (2021-2026)
  4. 3.4 Global Hydroxychloroquine (Plaquenil) Industry Manufacturers Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Hydroxychloroquine (Plaquenil) Key Manufacturers Manufacturing Sites & Headquarters
  6. 3.6 Global Hydroxychloroquine (Plaquenil) Manufacturers, Product Type & Application
  7. 3.7 Global Hydroxychloroquine (Plaquenil) Manufacturers Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Hydroxychloroquine (Plaquenil) Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Hydroxychloroquine (Plaquenil) Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Hydroxychloroquine (Plaquenil) Tier 1, Tier 2, and Tier 3
4 Hydroxychloroquine (Plaquenil) Market by Type
  1. 4.1 Hydroxychloroquine (Plaquenil) Type Introduction
  2. 4.1.1 100mg
  3. 4.1.2 200mg
  4. 4.1.3 Other
  5. 4.2 Global Hydroxychloroquine (Plaquenil) Sales by Type
  6. 4.2.1 Global Hydroxychloroquine (Plaquenil) Sales by Type (2021 VS 2025 VS 2032)
  7. 4.2.2 Global Hydroxychloroquine (Plaquenil) Sales by Type (2021-2032)
  8. 4.2.3 Global Hydroxychloroquine (Plaquenil) Sales Market Share by Type (2021-2032)
  9. 4.3 Global Hydroxychloroquine (Plaquenil) Revenue by Type
  10. 4.3.1 Global Hydroxychloroquine (Plaquenil) Revenue by Type (2021 VS 2025 VS 2032)
  11. 4.3.2 Global Hydroxychloroquine (Plaquenil) Revenue by Type (2021-2032)
  12. 4.3.3 Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Type (2021-2032)
5 Hydroxychloroquine (Plaquenil) Market by Application
  1. 5.1 Hydroxychloroquine (Plaquenil) Application Introduction
  2. 5.1.1 COVID-19
  3. 5.1.2 Rheumatoid Arthritis
  4. 5.1.3 Lupus Erythematosus
  5. 5.1.4 Others
  6. 5.2 Global Hydroxychloroquine (Plaquenil) Sales by Application
  7. 5.2.1 Global Hydroxychloroquine (Plaquenil) Sales by Application (2021 VS 2025 VS 2032)
  8. 5.2.2 Global Hydroxychloroquine (Plaquenil) Sales by Application (2021-2032)
  9. 5.2.3 Global Hydroxychloroquine (Plaquenil) Sales Market Share by Application (2021-2032)
  10. 5.3 Global Hydroxychloroquine (Plaquenil) Revenue by Application
  11. 5.3.1 Global Hydroxychloroquine (Plaquenil) Revenue by Application (2021 VS 2025 VS 2032)
  12. 5.3.2 Global Hydroxychloroquine (Plaquenil) Revenue by Application (2021-2032)
  13. 5.3.3 Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Application (2021-2032)
6 Global Hydroxychloroquine (Plaquenil) Sales by Region
  1. 6.1 Global Hydroxychloroquine (Plaquenil) Sales by Region: 2021 VS 2025 VS 2032
  2. 6.2 Global Hydroxychloroquine (Plaquenil) Sales by Region (2021-2032)
  3. 6.2.1 Global Hydroxychloroquine (Plaquenil) Sales by Region (2021-2026)
  4. 6.2.2 Global Hydroxychloroquine (Plaquenil) Sales Forecasted by Region (2027-2032)
  5. 6.3 North America
  6. 6.3.1 North America Hydroxychloroquine (Plaquenil) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  7. 6.3.2 North America Hydroxychloroquine (Plaquenil) Sales by Country (2021-2032)
  8. 6.3.3 U.S.
  9. 6.3.4 Canada
  10. 6.3.5 Mexico
  11. 6.4 Europe
  12. 6.4.1 Europe Hydroxychloroquine (Plaquenil) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  13. 6.4.2 Europe Hydroxychloroquine (Plaquenil) Sales by Country (2021-2032)
  14. 6.4.3 Germany
  15. 6.4.4 France
  16. 6.4.5 U.K.
  17. 6.4.6 Italy
  18. 6.4.7 Netherlands
  19. 6.5 Asia Pacific
  20. 6.5.1 Asia Pacific Hydroxychloroquine (Plaquenil) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  21. 6.5.2 Asia Pacific Hydroxychloroquine (Plaquenil) Sales by Country (2021-2032)
  22. 6.5.3 China
  23. 6.5.4 Japan
  24. 6.5.5 South Korea
  25. 6.5.6 Southeast Asia
  26. 6.5.7 India
  27. 6.5.8 Australia
  28. 6.6 South America, Middle East and Africa
  29. 6.6.1 South America, Middle East and Africa Hydroxychloroquine (Plaquenil) Sales Growth Rate by Country: 2021 VS 2025 VS 2032
  30. 6.6.2 South America, Middle East and Africa Hydroxychloroquine (Plaquenil) Sales by Country (2021-2032)
  31. 6.6.3 Brazil
  32. 6.6.4 South Africa
  33. 6.6.5 Saudi Arabia
  34. 6.6.6 Turkey
  35. 6.6.6 Argentina
  36. 6.6.6 UAE
  37. 6.6.6 Egypt
  38. 6.6.6 Chile
7 Global Hydroxychloroquine (Plaquenil) Revenue by Region
  1. 7.1 Global Hydroxychloroquine (Plaquenil) Revenue by Region
  2. 7.1.1 Global Hydroxychloroquine (Plaquenil) Revenue by Region: 2021 VS 2025 VS 2032
  3. 7.1.2 Global Hydroxychloroquine (Plaquenil) Revenue by Region (2021-2026)
  4. 7.1.3 Global Hydroxychloroquine (Plaquenil) Revenue by Region (2027-2032)
  5. 7.1.4 Global Hydroxychloroquine (Plaquenil) Revenue Market Share by Region (2021-2032)
  6. 7.2 North America
  7. 7.2.1 North America Hydroxychloroquine (Plaquenil) Revenue (2021-2032)
  8. 7.2.2 North America Hydroxychloroquine (Plaquenil) Revenue Share by Country: 2021 VS 2025 VS 2032
  9. 7.3 Europe
  10. 7.3.1 Europe Hydroxychloroquine (Plaquenil) Revenue (2021-2032)
  11. 7.3.2 Europe Hydroxychloroquine (Plaquenil) Revenue Share by Country: 2021 VS 2025 VS 2032
  12. 7.4 Asia-Pacific
  13. 7.4.1 Asia-Pacific Hydroxychloroquine (Plaquenil) Revenue (2021-2032)
  14. 7.4.2 Asia-Pacific Hydroxychloroquine (Plaquenil) Revenue Share by Country: 2021 VS 2025 VS 2032
  15. 7.5 South America, Middle East and Africa
  16. 7.5.1 South America, Middle East and Africa Hydroxychloroquine (Plaquenil) Revenue (2021-2032)
  17. 7.5.2 South America, Middle East and Africa Hydroxychloroquine (Plaquenil) Revenue Share by Country: 2021 VS 2025 VS 2032
8 Company Profiles
  1. 8.1 Actavis (TEVA )
  2. 8.1.1 Actavis (TEVA ) Company Information
  3. 8.1.2 Actavis (TEVA ) Business Overview
  4. 8.1.3 Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  5. 8.1.4 Actavis (TEVA ) Hydroxychloroquine (Plaquenil) Product Portfolio
  6. 8.1.5 Actavis (TEVA ) Recent Developments
  7. 8.2 Advanz Pharma
  8. 8.2.1 Advanz Pharma Company Information
  9. 8.2.2 Advanz Pharma Business Overview
  10. 8.2.3 Advanz Pharma Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  11. 8.2.4 Advanz Pharma Hydroxychloroquine (Plaquenil) Product Portfolio
  12. 8.2.5 Advanz Pharma Recent Developments
  13. 8.3 Aphena Pharma
  14. 8.3.1 Aphena Pharma Company Information
  15. 8.3.2 Aphena Pharma Business Overview
  16. 8.3.3 Aphena Pharma Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  17. 8.3.4 Aphena Pharma Hydroxychloroquine (Plaquenil) Product Portfolio
  18. 8.3.5 Aphena Pharma Recent Developments
  19. 8.4 Apotex Corporation
  20. 8.4.1 Apotex Corporation Company Information
  21. 8.4.2 Apotex Corporation Business Overview
  22. 8.4.3 Apotex Corporation Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  23. 8.4.4 Apotex Corporation Hydroxychloroquine (Plaquenil) Product Portfolio
  24. 8.4.5 Apotex Corporation Recent Developments
  25. 8.5 AvKARE (Amneal Pharmaceuticals)
  26. 8.5.1 AvKARE (Amneal Pharmaceuticals) Company Information
  27. 8.5.2 AvKARE (Amneal Pharmaceuticals) Business Overview
  28. 8.5.3 AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  29. 8.5.4 AvKARE (Amneal Pharmaceuticals) Hydroxychloroquine (Plaquenil) Product Portfolio
  30. 8.5.5 AvKARE (Amneal Pharmaceuticals) Recent Developments
  31. 8.6 Bristol Laboratories
  32. 8.6.1 Bristol Laboratories Company Information
  33. 8.6.2 Bristol Laboratories Business Overview
  34. 8.6.3 Bristol Laboratories Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  35. 8.6.4 Bristol Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio
  36. 8.6.5 Bristol Laboratories Recent Developments
  37. 8.7 Cadila Healthcare
  38. 8.7.1 Cadila Healthcare Company Information
  39. 8.7.2 Cadila Healthcare Business Overview
  40. 8.7.3 Cadila Healthcare Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  41. 8.7.4 Cadila Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio
  42. 8.7.5 Cadila Healthcare Recent Developments
  43. 8.8 Cardinal Health
  44. 8.8.1 Cardinal Health Company Information
  45. 8.8.2 Cardinal Health Business Overview
  46. 8.8.3 Cardinal Health Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  47. 8.8.4 Cardinal Health Hydroxychloroquine (Plaquenil) Product Portfolio
  48. 8.8.5 Cardinal Health Recent Developments
  49. 8.9 Cinkate Corporation
  50. 8.9.1 Cinkate Corporation Company Information
  51. 8.9.2 Cinkate Corporation Business Overview
  52. 8.9.3 Cinkate Corporation Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  53. 8.9.4 Cinkate Corporation Hydroxychloroquine (Plaquenil) Product Portfolio
  54. 8.9.5 Cinkate Corporation Recent Developments
  55. 8.10 Concordia Healthcare
  56. 8.10.1 Concordia Healthcare Company Information
  57. 8.10.2 Concordia Healthcare Business Overview
  58. 8.10.3 Concordia Healthcare Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  59. 8.10.4 Concordia Healthcare Hydroxychloroquine (Plaquenil) Product Portfolio
  60. 8.10.5 Concordia Healthcare Recent Developments
  61. 8.11 Covis Pharmaceutical
  62. 8.11.1 Covis Pharmaceutical Company Information
  63. 8.11.2 Covis Pharmaceutical Business Overview
  64. 8.11.3 Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  65. 8.11.4 Covis Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio
  66. 8.11.5 Covis Pharmaceutical Recent Developments
  67. 8.12 Hanlim Pharmaceutical
  68. 8.12.1 Hanlim Pharmaceutical Company Information
  69. 8.12.2 Hanlim Pharmaceutical Business Overview
  70. 8.12.3 Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  71. 8.12.4 Hanlim Pharmaceutical Hydroxychloroquine (Plaquenil) Product Portfolio
  72. 8.12.5 Hanlim Pharmaceutical Recent Developments
  73. 8.13 Hikma Pharmaceuticals
  74. 8.13.1 Hikma Pharmaceuticals Company Information
  75. 8.13.2 Hikma Pharmaceuticals Business Overview
  76. 8.13.3 Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  77. 8.13.4 Hikma Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio
  78. 8.13.5 Hikma Pharmaceuticals Recent Developments
  79. 8.14 Ipca Laboratories
  80. 8.14.1 Ipca Laboratories Company Information
  81. 8.14.2 Ipca Laboratories Business Overview
  82. 8.14.3 Ipca Laboratories Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  83. 8.14.4 Ipca Laboratories Hydroxychloroquine (Plaquenil) Product Portfolio
  84. 8.14.5 Ipca Laboratories Recent Developments
  85. 8.15 Kyung Poong
  86. 8.15.1 Kyung Poong Company Information
  87. 8.15.2 Kyung Poong Business Overview
  88. 8.15.3 Kyung Poong Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  89. 8.15.4 Kyung Poong Hydroxychloroquine (Plaquenil) Product Portfolio
  90. 8.15.5 Kyung Poong Recent Developments
  91. 8.16 Taj Pharmaceuticals
  92. 8.16.1 Taj Pharmaceuticals Company Information
  93. 8.16.2 Taj Pharmaceuticals Business Overview
  94. 8.16.3 Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  95. 8.16.4 Taj Pharmaceuticals Hydroxychloroquine (Plaquenil) Product Portfolio
  96. 8.16.5 Taj Pharmaceuticals Recent Developments
  97. 8.17 Zydus Cadila
  98. 8.17.1 Zydus Cadila Company Information
  99. 8.17.2 Zydus Cadila Business Overview
  100. 8.17.3 Zydus Cadila Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  101. 8.17.4 Zydus Cadila Hydroxychloroquine (Plaquenil) Product Portfolio
  102. 8.17.5 Zydus Cadila Recent Developments
  103. 8.18 Mylan
  104. 8.18.1 Mylan Company Information
  105. 8.18.2 Mylan Business Overview
  106. 8.18.3 Mylan Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  107. 8.18.4 Mylan Hydroxychloroquine (Plaquenil) Product Portfolio
  108. 8.18.5 Mylan Recent Developments
  109. 8.19 Novartis
  110. 8.19.1 Novartis Company Information
  111. 8.19.2 Novartis Business Overview
  112. 8.19.3 Novartis Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  113. 8.19.4 Novartis Hydroxychloroquine (Plaquenil) Product Portfolio
  114. 8.19.5 Novartis Recent Developments
  115. 8.20 Sanofi
  116. 8.20.1 Sanofi Company Information
  117. 8.20.2 Sanofi Business Overview
  118. 8.20.3 Sanofi Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  119. 8.20.4 Sanofi Hydroxychloroquine (Plaquenil) Product Portfolio
  120. 8.20.5 Sanofi Recent Developments
  121. 8.21 Shanghai Pharmaceuticals Holding
  122. 8.21.1 Shanghai Pharmaceuticals Holding Company Information
  123. 8.21.2 Shanghai Pharmaceuticals Holding Business Overview
  124. 8.21.3 Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  125. 8.21.4 Shanghai Pharmaceuticals Holding Hydroxychloroquine (Plaquenil) Product Portfolio
  126. 8.21.5 Shanghai Pharmaceuticals Holding Recent Developments
  127. 8.22 Sun Pharma
  128. 8.22.1 Sun Pharma Company Information
  129. 8.22.2 Sun Pharma Business Overview
  130. 8.22.3 Sun Pharma Hydroxychloroquine (Plaquenil) Sales, Price, Revenue and Gross Margin (2021-2026)
  131. 8.22.4 Sun Pharma Hydroxychloroquine (Plaquenil) Product Portfolio
  132. 8.22.5 Sun Pharma Recent Developments
9 Value Chain and Sales Channels Analysis
  1. 9.1 Hydroxychloroquine (Plaquenil) Value Chain Analysis
  2. 9.1.1 Hydroxychloroquine (Plaquenil) Key Raw Materials
  3. 9.1.2 Raw Materials Key Suppliers
  4. 9.1.3 Manufacturing Cost Structure
  5. 9.1.4 Hydroxychloroquine (Plaquenil) Production Mode & Process
  6. 9.2 Hydroxychloroquine (Plaquenil) Sales Channels Analysis
  7. 9.2.1 Direct Comparison with Distribution Share
  8. 9.2.2 Hydroxychloroquine (Plaquenil) Distributors
  9. 9.2.3 Hydroxychloroquine (Plaquenil) Customers
10 Concluding Insights
    11 Appendix
    1. 11.1 Reasons for Doing This Study
    2. 11.2 Research Methodology
    3. 11.3 Research Process
    4. 11.4 Authors List of This Report
    5. 11.5 Data Source
    6. 11.5.1 Secondary Sources
    7. 11.5.2 Primary Sources
    8. 11.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst